Companies in the therapeutics sector developing innovative solutions and technologies.
Explore 1,708 recently funded therapeutics companies with verified founder contact information and fundraising data.
mRNA therapeutics to extend healthspan entering clinical trials
We are developing a drug to burn calories and increase metabolism…
AI platform accelerating therapies for rare & inflammatory diseases.
Programmable DNA drug destroying all cancers, unlocking 80% of targets
Epsilogen is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.
Cairn Therapeutics transforms the treatment of cancer by overcoming the current limitations of the current therapies.
Blue Note Therapeutics is a prescription digital therapeutics company that merges deep scientific and clinical expertise.
KuriBio builds a nanotechnology platform for therapeutic applications in oncology and beyond.
Photys Therapeutics’ proprietary bifunctional small molecules platform unlocks fine-tuned control of protein modifications.
RecoveryOne provides physical therapy programs for people struggling with musculoskeletal issues.
Diadem is an innovative blood-based test exploiting a proprietary antibody targeting a specific conformation of p53 protein.
Otolith Labs develops a therapeutic device for the treatment of vertigo.
Carroucell is the microcarrier supplier for cell culture in bioreactor.
MitoChem Therapeutics develops treatments to address the effects of mitochondrial dysfunction in neurodegenerative, aging, and disease.
Ebumab is a biotechnology research company utilizing AMT technology in combination with the body’s own immune system to fight cancer.
OccuRx is a biopharmaceutical company that focuses on the development of innovative therapeutic strategies.
The therapeutics sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.
Therapeutics companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.
The therapeutics sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.
Here is how funding is distributed among the 1,708 therapeutics companies tracked in the VCBacked database.
Companies in the therapeutics sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.
Perfect for: B2B sales teams targeting therapeutics companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked